News

Check out our latest news and events below.

Access Accelerated Brings Together Leaders to Discuss NCD Solutions During UNGA Week



To a standing-room only audience atop McCann Worldgroup headquarters in New York City, Access Accelerated hosted a special UN General Assembly side event with multisector leaders working to tackle non-communicable diseases around the world. The event began with an interactive marketplace where nine Access Accelerated member companies–Astellas, Bristol-Myers Squibb, Eisai, Merck KGaA, Pfizer, Roche, Sanofi, Shionogi and Daiichi-Sankyo–showcased NCD access programs that address the deadliest NCDs like cancer, diabetes and heart disease.



Following the marketplace, Devex Editor-in-Chief Raj Kumar moderated a two-part speaker program. First, an engaging conversation with global cancer advocate and President-Elect of the Union for International Cancer Control (UICC), Her Royal Highness Dina Mired of Jordan. Princess Dina shared her personal story about why she became an advocate and detailed her work to establish cancer treatment in Jordan and beyond. Next, a second panel brought a diverse range of health professionals to the stage, including leading voices from the frontline of health care delivery, as well as the advocacy and programmatic levels, to discuss the challenges and opportunities to NCD care in Africa, Asia and Latin America.



The evening’s conversation touched on several significant, cross-cutting themes:

Focus on both short-term wins and long-term gains 
Princess Dina shared the story of a man who pointed out that in his country, there were no oncologists. Her pragmatic approach, which was critical in her tireless efforts to build the King Hussein Cancer Center in Jordan, became evident. She encouraged the man to leverage the short-term fix of using mobile diagnosis while working to train more doctors in the country. It is this mix of identifying short-term solutions and long-term capacity building that will drive progress in countries around the world. 

Local engagement–with patients, healthcare workers and governments–is an imperative 

UICC’s Dr. Susan Henshall and the Novartis Foundation’s Dr. Ann Aerts agreed on this point. Dr. Aerts noted that, while it might take longer to start a program, engaging local communities ultimately makes for a more effective program by addressing the real needs of patients and communities. Dr. Henshall discussed how the UICC C/CAN 2025 City Challenge brought people together and once they were really talking, they could pinpoint – and solve – community-specific barriers.


Begin with the country context

Professor Angelica Samudio, Dr. Chite Asirwa and Gomathi Kaliappan discussed specific programs in Paraguay, Kenya and India, respectively. Professor Samudio is the coordinator for My Child Matters, a project of Sanofi Espoir Foundations. She stressed the need to understand that it is not just public health challenges facing patients, but also the stress of poverty. Solutions, therefore, must be comprehensive and multifaceted. Dr. Asirwa is the Medical Co-Director of the AMPATH Oncology and Hematology Program. He discussed the need to address a critical barrier to NCD care–first, educating patients about cancer and its symptoms, and to encourage them to seek medical care quickly. Ms. Kaliappan, Project Lead for Roche India’s Blue Tree Oncology Patient Support Program, was asked why a company would not just donate funds. She responded that company involvement is vital to addressing real problems, understanding the patient journey, seeing the barriers and working with others to overcome challenges and provide NCD treatment and care.



Throughout the evening, Access Accelerated reinforced its commitment to public-private partnerships while thoughtful and engaging representatives shared ideas on best approaches and lessons learned. United Nations Foundation CEO and President Kathy Calvin closed the event by summarizing the powerful opportunity for initiatives like Access Accelerated:

  • Industry-wide partnerships (particularly ambitious ones) are critical to achieve the Sustainable Development Goals. “Business as usual” won’t get us there.
  • While multi-sectoral partnerships are by no means new, they are being designed more strategically and the alliance behind Access Accelerated is a powerful one.
  • In embracing a health issue responsible for 38 million deaths a year, Access Accelerated has taken on a lot of responsibility–and potential.  

Learn more about the latest news from Access Accelerated, and join the discussion about access to NCD care on Twitter.

  

TERMS OF USE

IFPMA (“we”, “us”) owns and operates www.ifpma.org (“the/our website”). Any person accessing and/or using the website (“the visitor/user”) agrees to the “Terms of Use”, containing the conditions, rules and other provisions with respect to the access and/or use of our website. If you have questions about the “Terms of Use”, please feel free to contact us at admin@ifpma.org.

CONTENT

General Use

The material contained on this website is for information only. The website is entitled to be served as an information resource for the internal and external stakeholders of IFPMA, including the general public. Third-Party Websites Links to other websites are provided solely as a convenience and therefore imply neither IFPMA’s responsibility for, nor its approval of the information contained in these websites. Intellectual Property Any use of information from the website should have an acknowledgement of IFPMA/Third-Party as a source respectively, citing the corresponding uniform resource locator (URL). Logo and Name The use of IFPMA’s name and/or logo is prohibited without prior express authorization from IFPMA. The access and/or use of the website does not permit to copy, reproduce, modify, distribute or elsehow exploit IFPMA’s name and/or logo except with the prior explicit permission. Abuse and Violation Any abuse or violations of the Terms of Use and/or Privacy Policy should be reported to admin@ifpma.org.

DISCLAIMER

IFPMA renounces any liability or responsibility for any damages of any nature whatsoever resulting from the use of, inability to use, and/or reliance on the material and information contained on our website. IFPMA makes no representations or warranties as to the completeness or accuracy of any of the information available on the website as well as does not provide any warranties regarding the security of the content of our website or any linked websites. IFPMA endeavours to make its best effort to keep the information accurate and updated on a regular basis, however this is not claimed to be exhaustive. IFPMA does not guarantee that the website is continuously available and error-free at all times.

Privacy Policy

IFPMA is committed to protecting the privacy and security of visitors to our website. Outlined below is our online privacy policy for information collected through our website. If you have questions about these policies, please feel free to contact us at admin@ifpma.org.

Personal Information

We constantly analyse our website logs to improve the value of our website. We do not use this analysis to record or track any personally identifiable information of our visitors. If you are asked to provide personal information such as your name, e-mail or/and postal address when requesting information, providing feedback, registering to a newsletter, or using any other functions of the website, be assured that all such information is considered by IFPMA both private and secure. IFPMA does not share or sell your personal information to third parties. Under no circumstance will details be disclosed publicly, except in order to comply with any legal obligation. This policy reiterates that IFPMA fully appreciates the importance of online privacy and is committed to protecting your personal information.

Use of Cookies Files

Our website is enhanced by cookie files to personalize and customize the experience of our visitors and to support some necessary functions. IFPMA collects broad usage statistics using Google Analytics, to better understand how our visitors use our website, and to help us improve visitors’ experience. Such information includes the IP address (where available), browser type, and any additional information provided by a browser during the use of our website. The statistical data about our users’ browsing actions and patterns does not identify any individual. You may choose to accept or refuse cookies by modifying your browser preferences. If you wish to get notified when a cookies are set, this option should also be available in your browser settings. Please note that if you reject some or all cookies, your experience at this and other websites throughout the Internet may not be complete.

Payment Transactions

To enable IFPMA to process any order or registration to an event, a secure online payment system may be used to process payments using credit card details. IFPMA will not be collecting or storing credit card details in our system.

Third-Party Websites

Please be aware that other websites to which links may be provided, including social media, may collect visitor’s personally identifiable information when accessed. The information collection practices of other websites linked to IFPMA’s website are not covered by this Privacy Policy.